| Primary |
| Nausea |
14.7% |
| Product Used For Unknown Indication |
13.3% |
| General Anaesthesia |
10.0% |
| Hyperemesis Gravidarum |
9.3% |
| Prophylaxis Of Nausea And Vomiting |
8.7% |
| Vomiting |
6.0% |
| Anaesthesia |
4.7% |
| Drug Use For Unknown Indication |
4.7% |
| Premedication |
4.7% |
| Chemotherapy |
4.0% |
| Pain |
4.0% |
| Depression |
2.7% |
| Prophylaxis |
2.7% |
| Analgesic Therapy |
2.0% |
| Anxiety |
2.0% |
| Breast Cancer |
1.3% |
| Colon Cancer Stage Iv |
1.3% |
| Colon Neoplasm |
1.3% |
| Constipation |
1.3% |
| Large Cell Lung Cancer Recurrent |
1.3% |
|
| Ventricular Tachycardia |
15.4% |
| Torsade De Pointes |
12.8% |
| Vomiting |
10.3% |
| Nausea |
7.7% |
| Tearfulness |
7.7% |
| Somnolence |
5.1% |
| Tremor |
5.1% |
| Ventricular Extrasystoles |
5.1% |
| Brain Death |
2.6% |
| Chest Discomfort |
2.6% |
| Chills |
2.6% |
| Congenital Musculoskeletal Anomaly |
2.6% |
| Constipation |
2.6% |
| Coronary Artery Disease |
2.6% |
| Diarrhoea |
2.6% |
| Drug Exposure During Pregnancy |
2.6% |
| Drug Ineffective |
2.6% |
| Drug Interaction |
2.6% |
| Dyskinesia |
2.6% |
| Electrocardiogram Qt Prolonged |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
21.5% |
| Prophylaxis Of Nausea And Vomiting |
16.9% |
| Drug Use For Unknown Indication |
7.1% |
| Nausea |
6.2% |
| Premedication |
5.2% |
| Breast Cancer |
5.0% |
| Analgesic Therapy |
3.9% |
| Drug Exposure During Pregnancy |
3.8% |
| Synovial Sarcoma |
3.8% |
| Anaesthesia |
3.6% |
| Vomiting |
3.3% |
| Prophylaxis |
2.8% |
| Small Intestine Carcinoma |
2.8% |
| Non-small Cell Lung Cancer Stage Iii |
2.5% |
| Pain |
2.5% |
| Lung Neoplasm Malignant |
2.4% |
| Rectal Cancer |
1.9% |
| Bone Sarcoma |
1.7% |
| Hypertension |
1.6% |
| Diffuse Large B-cell Lymphoma |
1.4% |
|
| Drug Exposure During Pregnancy |
8.6% |
| Completed Suicide |
7.1% |
| Electrocardiogram T Wave Inversion |
7.1% |
| Transaminases Increased |
7.1% |
| Vomiting |
7.1% |
| Caesarean Section |
5.7% |
| Laryngeal Dyspnoea |
5.7% |
| Venoocclusive Liver Disease |
5.7% |
| Drug Interaction |
4.3% |
| Encephalopathy |
4.3% |
| Paraesthesia |
4.3% |
| Rash Pruritic |
4.3% |
| Sense Of Oppression |
4.3% |
| Serotonin Syndrome |
4.3% |
| Sinus Arrhythmia |
4.3% |
| Unresponsive To Stimuli |
4.3% |
| Acute Myocardial Infarction |
2.9% |
| Anaphylactic Shock |
2.9% |
| Cytolytic Hepatitis |
2.9% |
| Diarrhoea |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.7% |
| Drug Use For Unknown Indication |
20.1% |
| Nausea |
6.2% |
| Pain |
5.3% |
| Non-small Cell Lung Cancer |
4.0% |
| Prophylaxis |
3.9% |
| Colorectal Cancer |
2.9% |
| Hypertension |
2.8% |
| Prophylaxis Of Nausea And Vomiting |
2.8% |
| Vomiting |
2.5% |
| Constipation |
1.6% |
| Anxiety |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Breast Cancer |
1.4% |
| Multiple Myeloma |
1.4% |
| Premedication |
1.4% |
| Colon Cancer |
1.3% |
| Acute Myeloid Leukaemia |
1.3% |
| Colorectal Cancer Metastatic |
1.2% |
| Acute Lymphocytic Leukaemia |
1.1% |
|
| Vomiting |
24.2% |
| Renal Failure Acute |
7.7% |
| Weight Decreased |
6.5% |
| Sepsis |
5.5% |
| Thrombocytopenia |
5.5% |
| Nausea |
5.2% |
| Pyrexia |
4.8% |
| Pulmonary Embolism |
4.5% |
| Anaemia |
4.2% |
| Cerebrovascular Accident |
3.9% |
| Tachycardia |
3.9% |
| Renal Failure |
3.2% |
| White Blood Cell Count Decreased |
3.2% |
| Death |
2.9% |
| Colitis |
2.6% |
| Decreased Appetite |
2.6% |
| Urinary Tract Infection |
2.6% |
| Venoocclusive Disease |
2.6% |
| Diarrhoea |
2.3% |
| Febrile Neutropenia |
2.3% |
|
| Interacting |
| Hepatosplenic Candidiasis |
36.4% |
| Depression |
18.2% |
| Nausea |
18.2% |
| Anaesthesia |
9.1% |
| Hypotonia |
9.1% |
| Vomiting |
9.1% |
|
| Atrioventricular Block Second Degree |
40.0% |
| Sinoatrial Block |
40.0% |
| Drug Interaction |
20.0% |
|
